Effectiveness of low dose Aspirin, calcium supplementation and both in preventing preeclampsia

Prevention of early-onset preeclampsia in high-risk pregnant women: A comparative study of low-dose Aspirin, calcium supplementation and the combination of both

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202601561203581

Enrollment

210

Registered

2026-01-20

Start date

2025-11-03

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

Aspirin

Aspirin plus calcium

Calcium

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: all booked pregnant women at high risk of preeclampsia

Exclusion criteria

Exclusion criteria: all pregnant women at gestation ages 33weeks all pregnant women with gestational hypertension or preeclampsia in the index pregnancy all pregnant women with allergy or contraindication to aspirin or calcium all pregnant women who do not consent to the study

Design outcomes

Primary

Measure	Time frame
to compare the incidence of early onset preeclampsia in the three groups	—

Secondary

Measure	Time frame
to compare the incidence of severe preeclampsia in the three groups;to compare the drug adherence in the three groups	—

Countries

Nigeria

Contacts

Public ContactSukariba Matthew

Nurse

matthewsuka.sm@gmail.com+2348160509598

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026